ARTICLE | Distillery Therapeutics
Therapeutics: TOR signaling pathway regulator (TIPRL); protein phosphatase 2 regulatory subunit A α (PPP2R1A)
August 18, 2016 7:00 AM UTC
Cell culture studies suggest inhibiting TIPRL could help treat PPP2R1A-mutant endometrial cancer. In a human PPP2R1A-mutant endometrial carcinoma cell line, shRNA targeting TIPRL - a binding partner o...